×
About 2,047 results

ALLMedicine™ Juvenile Myoclonic Epilepsy Center

Research & Reviews  699 results

Challenges in the treatment of a chronic disease: A study of narratives of people with ...
https://doi.org/10.1016/j.seizure.2021.04.004
Seizure Contier ATR, Alonso NB et. al.

Apr 11th, 2021 - The purpose of this study was to explore how people with juvenile myoclonic epilepsy perceive the impact of treatment. We conducted 14 interviews of participants with juvenile myoclonic epilepsy recruited with the support of the Brazilian Associat...

Juvenile myoclonic epilepsy: Long-term prognosis and risk factors.
https://doi.org/10.1016/j.braindev.2021.02.005
Brain & Development; Pietrafusa N, La Neve A et. al.

Mar 30th, 2021 - Our goal was to investigate the long-term clinical course of juvenile myoclonic epilepsy (JME) in a cohort of patients and to identify prognostic factors for refractoriness and seizure relapse after anti-seizure medications (ASMs) withdrawal. A li...

Social outcome and psychiatric comorbidity of generalized epilepsies - A case-control s...
https://doi.org/10.1111/epi.16870
Epilepsia Gesche J, Antonson S et. al.

Mar 18th, 2021 - To investigate social outcome and psychiatric comorbidity of patients with idiopathic/genetic generalized epilepsies (IGEs) and its subtypes (epilepsy with generalized tonic-clonic seizures alone [EGTCS], juvenile absence epilepsy [JAE], and juven...

Prolonged epileptic discharges predict seizure recurrence in JME: Insights from prolong...
https://doi.org/10.1111/epi.16875
Epilepsia Turco F, Bonanni E et. al.

Mar 18th, 2021 - Markers of seizure recurrence are needed to personalize antiseizure medication (ASM) therapy. In the clinical practice, EEG features are considered to be related to the risk of seizure recurrence for genetic generalized epilepsies (GGE). However, ...

A computational biomarker of juvenile myoclonic epilepsy from resting-state MEG.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992031
Clinical Neurophysiology : Official Journal of the Intern... Lopes MA, Krzemiński D et. al.

Feb 26th, 2021 - For people with idiopathic generalized epilepsy, functional networks derived from their resting-state scalp electrophysiological recordings have shown an inherent higher propensity to generate seizures than those from healthy controls when assesse...

see more →

Guidelines  1 results

Practice guideline update summary: Efficacy and tolerability of the new antiepileptic d...
https://doi.org/10.1212/WNL.0000000000005755
Neurology Kanner AM, Ashman E et. al.

Jun 14th, 2018 - To update the 2004 American Academy of Neurology (AAN) guideline for treating new-onset focal or generalized epilepsy with second- and third-generation antiepileptic drugs (AEDs). The 2004 AAN criteria were used to systematically review literature...

see more →

Drugs  313 results see all →

Clinicaltrials.gov  1,019 results

Challenges in the treatment of a chronic disease: A study of narratives of people with ...
https://doi.org/10.1016/j.seizure.2021.04.004
Seizure Contier ATR, Alonso NB et. al.

Apr 11th, 2021 - The purpose of this study was to explore how people with juvenile myoclonic epilepsy perceive the impact of treatment. We conducted 14 interviews of participants with juvenile myoclonic epilepsy recruited with the support of the Brazilian Associat...

Levetiracetam - levetiracetam tablet-A-S Medication Solutions
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2d2af1f9-51a5-4ba4-89a2-451e8ed049f7

Mar 31st, 2021 - Levetiracetam tablets are indicated for the treatment of partial- onset seizures in patients 1 month of age and older (1.1) Levetiracetam tablets are indicated for adjunctive therapy for the treatment of: Myoclonic seizures in patients 12 years of...

Juvenile myoclonic epilepsy: Long-term prognosis and risk factors.
https://doi.org/10.1016/j.braindev.2021.02.005
Brain & Development; Pietrafusa N, La Neve A et. al.

Mar 30th, 2021 - Our goal was to investigate the long-term clinical course of juvenile myoclonic epilepsy (JME) in a cohort of patients and to identify prognostic factors for refractoriness and seizure relapse after anti-seizure medications (ASMs) withdrawal. A li...

Levetiracetam - levetiracetam tablet, film coated-Cardinal Health
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e1b14939-7262-40dc-a334-2b3b72c88d47

Mar 29th, 2021 - Levetiracetam tablets are indicated for adjunctive therapy in the treatment of: •Partial onset seizures in patients one month of age and older with epilepsy ( 1.1) •Myoclonic seizures in patients 12 years of age and older with juvenile myoclonic e...

Levetiracetam - levetiracetam injection-Hikma Pharmaceuticals USA Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=097e5606-dd5e-4518-ab97-f71f68786444

Mar 24th, 2021 - Levetiracetam Injection is indicated for the treatment of partial-onset seizures in patients 1 month of age and older (1.1) • Levetiracetam Injection is indicated for adjunctive therapy for the treatment of: Myoclonic seizures in patients 12 years...

see more →

News  15 results

Hippocampal abnormalities seen in epilepsy subtypes may be congenital
https://www.mdedge.com/pediatrics/article/191658/epilepsy-seizures/hippocampal-abnormalities-seen-epilepsy-subtypes-may-be
Michele G. Sullivan

Dec 20th, 2018 - NEW ORLEANS – Abnormalities of hippocampal volume and morphology in children with temporal lobe or juvenile myoclonic epilepsy (JME) are also present in the brains of their unaffected siblings, although to a lesser extent, based on findings from t.

Unique MRI Findings in Juvenile Myoclonic Epilepsy
https://www.mdedge.com/neurology/epilepsyresourcecenter/article/178020/epilepsy-seizures/unique-mri-findings

Oct 24th, 2018 - The cortical regions of the brains of patients with juvenile myoclonic epilepsy (JME) are more likely to be disassociated from subcortical structures, according to a recent study that compared the MRI readings of JME patients to those of normal ch.

Variants in One Gene May Account for 7% of Juvenile Myoclonic Epilepsy Cases
https://www.mdedge.com/neurology/article/164739/epilepsy-seizures/variants-one-gene-may-account-7-juvenile-myoclonic/page/0/2

May 2nd, 2018 - “The data we obtained through the use of electroporated slices of mouse brain support the conclusion that pathogenic variants in ICK cause 7% of cases of juvenile myoclonic epilepsy by disrupting mitosis, neuroblast migration, and apoptosis,” they.

Variants in one gene account for 7% of juvenile myoclonic epilepsy cases
https://www.mdedge.com/neurology/article/160858/epilepsy-seizures/variants-one-gene-account-7-juvenile-myoclonic-epilepsy
Michele G. Sullivan

Mar 14th, 2018 - An extremely rare genetic variant that affects the maturation, migration, and death of neurons appears to be responsible for about 7% of cases of juvenile myoclonic epilepsy. Variants of the intestinal-cell kinase gene (ICK) occurred in 12 members.

see more →